Clinical Trials Browser

Ovarian Neoplasms × pamiparib × 90 days × Clear all

NCT03519230 2026-03-16

Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer

Phase 3 Active not recruiting

Ovarian Neoplasms